pocketful logo light
pocketful logo light
Themis Medicare Ltd logo

Themis Medicare Ltd

NSE: THEMISMED BSE: 530199

₹101.73

(0.08%)

Sun, 28 Jun 2026, 11:16 pm

Themis Medicare Share Price Live Chart

1 Day

(0.08%)

No Result Found

Summary

  • Market Cap (in Cr)

    1012.55

  • Net Profit (in Cr)

    29.83

  • P/B

    3.65

  • Sector P/E

    33.76

  • P/E

    45.26

  • EV/EBITDA

    23.81

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    8.36

  • ROCE

    11.09

  • Debt/Equity

    0.25

  • EPS (TTM)

    0.18

  • Dividend Yield

    0

  • Book Value

    39.70

  • Interest Cover

    4.95

Analysis

all

thumbs up icon

Pros

  • Dividends paid are thoroughly covered by earnings (15.4x coverage).
  • Themis Medicare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 2x debt.
thumbs up icon

Cons

  • Dividends per share have fallen over the past 10 years.
  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Themis Medicare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Themis Medicare's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Debt is not well covered by operating cash flow (0.4%, less than 20% of total debt).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters67.1167.1167.1567.1567.15
FII0.110.050.060.000.14
DII0.010.010.010.010.01
Public32.7832.8332.7832.8332.70
Government00000

Read More

Technical Analysis

RSI

60.20

MACD

3.90

50 DMA

101.14

200 DMA

101.69

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic153.30130.23119.90107.1696.8384.0961.02
Fibonacci130.23121.42115.98107.1698.3592.9184.09
Camarilla115.90113.79111.67107.16107.45105.33103.22

Pivots Level: Classic

R3

+46.14

153.30

R2

+23.07

130.23

R1

+12.73

119.90

107.16
107.16
Pivot Point
LTP: 114.33

S1

-10.34

96.83

S2

-23.07

84.09

S3

-46.14

61.02

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    110.88

  • 20-EMA

    107.60

  • 30-EMA

    105.21

  • 50-EMA

    101.46

  • 100-EMA

    98.49

  • 200-EMA

    106.24

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
13 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
19 Aug 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 0.505 Sept 2025
04 Aug 2025dividendDividend - Re 0.50 Per Share05 Sept 2025
20 May 2025dividend₹0.50 Dividend /Share05 Sept 2025
12 Jun 2024dividendAnnual General Meeting/Dividend - Rs 0.50 Per Share15 Jul 2024
14 May 2024dividend₹0.50 Dividend /Share15 Jul 2024
14 May 2024agm
10 Sept 2023splitStock Split From Rs.10 to Rs.110 Oct 2023

Read More

Peer Comparison

Themis Medicare Ltd logo

Themis Medicare Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Themis Medicare Ltd About

Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products especially in Formulation and API activity.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1969

Headquarters

CEO

Dinesh S Patel

Employees

Contact

Website icon

Website

http://www.themismedicare.com

Email icon

Email

sangameshwar.iyer@themismedicare.com; cfoassist@th

Phone icon

Phone

91-260-2421675

Location icon

Location

Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195

Read More

Themis Medicare Ltd Company History

YearHistory
2011
  • Themis Medicare introduced a 'calcium' preparation with fruity gummies for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare introduced a 'Multivitamin' for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare launched the brand LUMIXYL, entering the COSMETO-DERMATOLOGY segment.
2013
  • Themis Medicare Limited entered into a License and Supply Agreement with Novartis India Limited to supply Diclofenac topical gel.
  • Themis Medicare Ltd entered into a Supply & Distribution Agreement with Novartis India Ltd to supply Diclofenac Sodium 75mg per ml Injection.
2014
  • Themis invented Aquadol Spass 1ml Injection and commenced production, marketing, and sales.
2022
  • Inosine Pranobex, a unique Immunomodulator drug, received use approval from The Drug Controller General of India for the treatment of COVID-19.
2023
  • The Company has split its face value from Rs. 10/- to Rs. 1/-.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy685949141.6109 Oct 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell659356141.6309 Oct 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell685949141.7209 Oct 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy659356141.3209 Oct 2025
TEJAS TRADEFIN LLPbulkBuy72009735.7602 Jun 2021
GAGANDEEP CREDIT CAPITAL PRIVATE LIMITEDbulkSell11250060.2512 Mar 2013
ANUJ ANANTRAI SHETHbulkBuy11250060.2512 Mar 2013
KISHORCHAND RATULSIDAS LAKDAWALAbulkSell235712181.526 Mar 2010
THEMIS DISTRIBUTORS PVT. LTD.bulkBuy234612181.526 Mar 2010
KISHOR CHANDRA TULSIDAS LAKDAWALAbulkSell8997617504 Mar 2010

Read More

Themis Medicare Ltd News

Themis Medicare board to meet on May 28

Themis Medicare Limited's board will meet on May 28 to consider FY26 results and dividend recommendation. Trading window closed from April 1.

26 May 2026

companies

Themis Medicare Files Warrants Valuation Report

Themis Medicare submits valuation report and updated compliance certificate to BSE and NSE for preferential allotment of convertible warrants under Regulation 30.

12 May 2026

companies

Themis Medicare Opens Special Window for Share Transfers

Themis Medicare Limited announces special window from February 05, 2026 to February 04, 2027 for re-lodgement of transfer requests and dematerialization of physical shares pursuant to SEBI circular dated January 30, 2026.

08 Apr 2026

companies

Themis Medicare Postal Ballot Results Announced

Themis Medicare Limited announces successful completion of postal ballot with all four resolutions passed. The voting covered material related party transactions and convertible warrant issuance.

28 Mar 2026

companies

Themis Medicare Postal Ballot Results Announced

Themis Medicare Limited announces successful completion of postal ballot with all four resolutions passed. The voting covered material related party transactions and convertible warrant issuance.

28 Mar 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number